Sensory and Cognitive Outcomes of Robotic Exercises in Stroke (SCORES)
SCORES
A Multicenter Randomized Controlled Trial on the Effects of Upper Limb Robotic Rehabilitation on Sensory and Cognitive Impairments in Subjects With Stroke. The SCORES (Sensory and Cognitive Outcomes of Robotic Exercises in Stroke) Study.
1 other identifier
interventional
126
1 country
3
Brief Summary
Based on the findings of meta-analyses, upper limb robotic rehabilitation has shown to enhance daily living activities, motor function, and strength in stroke patients. However, when compared to traditional methods, recent randomized controlled trials conducted on larger participant groups failed to identify significant differences in motor-related outcomes between the two approaches. In addition to motor deficits, stroke survivors often experience cognitive decline and sensory disturbances, which can significantly impede their recovery process. The introduction of multisensory stimulation and an enriched environment through robotic interventions may offer valuable supplementary treatments in these specific areas. Nevertheless, this aspect of treatment has not been thoroughly explored. This study seeks to assess the effectiveness of upper limb robotic rehabilitation in individuals recovering from subacute strokes, in comparison to conventional treatments. Specifically, it aims to determine whether this robotic therapy can lead to improvements in (a) cognitive deficits, (b) somatosensory impairment, and (c) how these sensory and cognitive deficits influence the process of motor recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started Nov 2023
Typical duration for not_applicable stroke
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2023
CompletedFirst Posted
Study publicly available on registry
October 31, 2023
CompletedStudy Start
First participant enrolled
November 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedOctober 15, 2024
October 1, 2024
1.5 years
October 23, 2023
October 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Montreal Cognitive Assessment
It is a validated test of cognitive impairment. It ranges from 0 (indicating worse cognitive function) to 30 (best cognitive function).
Baseline, up to 7 days after the enrollment; up to 3 days after the intervention
Secondary Outcomes (17)
Changes in Montreal Cognitive Assessment
Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention
Changes in Symbol Digit Modalities Test
Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention
Changes in Tower of London
Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention
Changes in Rey-Osterrieth Complex Figure test
Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention
Changes in Visual search test
Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention
- +12 more secondary outcomes
Other Outcomes (9)
Changes in robotic score duration
Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention
Changes in robotic score speed
Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention
Changes in robotic score length
Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention
- +6 more other outcomes
Study Arms (2)
Robotic Rehabilitation
EXPERIMENTALConventional treatment
ACTIVE COMPARATORInterventions
Upper limb rehabilitation using a set of 4 devices. A set of motor/cognitive exercises will be selected to train also attention, memory, executive function, speed of processing, and visuospatial abilities.The following devices will be used: (a) a robotic device that allows passive, active, and active-assistive planar movements of the shoulder and elbow joints (Motore, Humanware); (b) a robotic device that allows passive, active, and active-assistive finger flexion and extension movements (Amadeo, Tyromotion); (c) a sensor-based system that allows unsupported 3-dimensional movements of shoulder, elbow, and wrist joint, both unimanual and bimanual (Pablo, Tyromotion); and (d) a robotic system that allows 3-dimensional, unimanual and bimanual, movements of the shoulder joint, with arm weight support (Diego, Tyromotion). The rehabilitation treatment will be performed daily for 45 minutes, 5 days/week, for a total of 30 sessions.
Upper limb rehabilitation using conventional techniques, focused on upper limb reprogramming sensorimotor function, hypertonus, inhibition and functional improvement. The rehabilitation treatment will be performed daily for 45 minutes, 5 days/week, for a total of 30 sessions.
Eligibility Criteria
You may qualify if:
- a single event, verified by MRI or CT;
- age between 18 and 85 years;
- time since stroke within six months;
- a demographically adjusted total score of the Montreal Cognitive Assessment (MoCA) between 15.5 and 22.23
You may not qualify if:
- behavioural and cognitive disorders and/or reduced compliance that would interfere with active therapy;
- fixed contraction deformity in the affected limb that would interfere with active therapy (ankylosis, Modified Ashworth Scale = 4);
- severe deficits in visual acuity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondazione Don Carlo Gnocchi Onluslead
- IRCCS Centro Neurolesi Bonino Pulejocollaborator
- Scuola Superiore Sant'Anna di Pisacollaborator
Study Sites (3)
IRCCS Fondazione Don Carlo Gnocchi
Florence, 50143, Italy
IRCCS Centro Neurolesi Bonino Pulejo
Messina, 98123, Italy
Fondazione Don Carlo Gnocchi - Centro Santa Maria della Provvidenza
Roma, 00166, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Marco Germanotta, PhD
IRCCS Fondazione Don Carlo Gnocchi
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2023
First Posted
October 31, 2023
Study Start
November 13, 2023
Primary Completion
May 1, 2025
Study Completion
January 1, 2026
Last Updated
October 15, 2024
Record last verified: 2024-10